APONTIS PHARMA AG
ISIN: DE000A3CMGM5 | Ticker: APPH
APONTIS PHARMA AG is a leading pharmaceutical company in Germany that specialises in single pills. Single Pills combine two to three generic active ingredients in one combination preparation. APONTIS PHARMA develops, markets and distributes a broad portfolio of Single Pills and other medicines, with a particular focus on cardiovascular diseases. Since 2013, APONTIS has successfully launched several Single Pills solely for cardiovascular indications such as hypertension, hyperlipidaemia and secondary prevention. With its headquarters in Monheim am Rhein, APONTIS PHARMA is located in the heart of Europe's strongest pharmaceutical and chemical region. From here, the company maintains a broad network with research-based pharmaceutical companies and a target customer group of around 23,000 doctors in Germany.
Year founded1946
Served areaGermany
Headcount168
HeadquartersAlfred-Nobel-Str. 10, 40789 Monheim – Germany
8,500,000
IPOMay 11, 2021
Designated Sponsor(s)Hauck Aufhäuser Lampe Privatbank AG
Stock exchange(s)Frankfurt Stock Exchange